Comparative Translational Research: Safety and Efficacy of an NK Cell Therapy for Treating Bone Tumors

William Kisseberth, DVM, MS, PhD, and Dean Lee, MD, PhD, collaborated to use a natural animal model of disease, specifically dogs with tumors, to test the safety and efficacy of a new therapy for treating bone tumors. These canine tumors are very similar to those found in people, making the model especially effective for validating the therapy before moving to human clinical trials.

This is the third in a series of programs from the Ohio State Center for Clinical and Translational Science Comparative and Translational Medicine program highlighting how the use of spontaneous animal models of disease can create an integrated platform for collaborative research, therapeutic interrogation, cross-disciplinary training and outreach across Ohio State, Nationwide Children's Hospital and partners.

Mark your calendar for July 26 at noon for the fourth program in the series, Testing a Wearable Joint Monitoring Device on Dogs.

Dr. Kisseberth is Professor of Veterinary Clinical Sciences in the College of Veterinary Medicine at Ohio State and Dr. Lee is Professor of Pediatrics and he DiMarco Family Endowed Chair in Cell Based Therapy at Nationwide Children's Hospital and the Ohio State College of Medicine.